Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Ventura2020on Jan 27, 2022 10:08pm
263 Views
Post# 34369639

MedMen once promised to be the Apple of Cannabis.

MedMen once promised to be the Apple of Cannabis.

Ten years later, its former CEO dishes on how it all went wrong.
Jan 24, 2022, 7:33 AM

Good read!

https://www.businessinsider.com/adam-bierman-cannabis-medmen-ceo-tenure-2022-1

The company is still in business, though a shell of its former self. Canadian cannabis company Tilray bought up a chunk of its debt in August and MedMen has a new interim CEO in Michael Serruya, its third since Bierman was forced out in early 2020.

"Today, MedMen is a new company with a new vision and new leadership team. We are focused on moving forward, and driving our brand toward an exciting 2022," MedMen Chief Revenue Officer Tracy McCourt said in an emailed statement. 
<< Previous
Bullboard Posts
Next >>